In 2023, the value for Pharmaceuticals in Dosage Market Size per capita in Finland stands at USD 893.42. Forecasts suggest a steady decline in the market size value per capita over the next five years. In 2024, the projected value is USD 869.05, a decrease of 2.73% compared to the previous year. By 2025, this further declines by 2.80% to USD 844.68. The trend continues with a 2.65% decrease in 2026 to USD 820.55, a 2.92% fall in 2027 to USD 796.65, and a 3.02% reduction in 2028 to USD 772.98.
Key Trends Observed:
- Year-on-year values indicate a consistent downward trajectory.
- The cumulative average growth rate (CAGR) over the period from 2024 to 2028 is -3.09%.
Future trends to watch for include potential market disruptions due to regulatory changes, advancements in pharmaceutical technology, and shifts in consumer behavior and healthcare policies in Finland.
